Mizuho Securities Remains Bullish on Tiffany & Co. (TIF) Despite Weak Holiday Sales - PT to $75
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/5/2026
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- US nonfarm payrolls blow past expectations in August; unemployment rate steady at 4.1%
- BofA's Hartnett says stay long commodities and gold as 'policy panic' works
- Oil ends week higher on renewed US-Iran strikes, diesel hits record
- TikTok owner ByteDance said to secure $29.6bn loan for AI push
- S&P Dow Jones Indices adds Bloom Energy to S&P 500 index
- Citi highlights best Gen AI stocks to own for 2027
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- Netflix raises prices in Germany and Austria, Citi comments
- Wall Street ends lower as solid jobs data fuels hawkish Fed bets
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Pre-Open Stock Movers 01/19: (RSE) (ZPIN) (SHOP) Higher; (EBIO) (TIF) (MKC) Lower (more...)
January 19, 2016 9:33 AM ESTEleven Biotherapeutics, Inc. (NASDAQ: EBIO) 64% LOWER; announced top-line results from the Phase 3 clinical trial of its lead drug candidate, isunakinra (EBI-005), for the treatment of severe allergic conjunctivitis. In this trial, there were no statistically significant differences between the isunakinra treated group and the vehicle control group on the primary endpoint of ocular itching or on any secondary endpoints. Isunakinra was generally well tolerated, with 94% of the patients completing the trial and there were no serious adverse events reported.
Rouse Properties, Inc. (NYSE:... More
S&P 500 ends unchanged; more carnage in oil stocks
January 19, 2016 7:30 AM ESTBy Noel Randewich
(Reuters) - Wall Street ended flat after a choppy session on Tuesday as falling oil prices led to more carnage in energy stocks and an "in line" economic report showed slower growth in China.
Declining U.S. crude pulled down materials stocks as well as the S&P energy sector , which slumped 2.17 percent.
Oil at 12-year lows is stoking fears on Wall Street of deeper losses for energy companies and the potential that some may fail to pay their debts. That has decimated oil stocks, helping push the S&P 500 down 8... More
Tiffany & Co. (TIF) Holiday Comps Fell 5%; FY15 Outlook Trimmed
January 19, 2016 6:41 AM ESTTiffany & Co. (NYSE: TIF) reported its sales results for the two-month period ended December 31st (holiday period). Results were negatively affected by the strong U.S. dollar and weak tourist spending in a number of markets. On a constant-exchange-rate basis that excludes the effect of translating foreign-currency-denominated sales into U.S. dollars (see Non-GAAP Measures schedule), worldwide net sales declined 3% (due to declines in the Americas and Asia-Pacific offsetting growth in Japan and Europe) and comparable store sales declined 5%. There were no noteworthy differences in performance among jewelry categories. Reported in U.S. dollars, worldwide net... More
Tiffany & Co. (TIF) Gains on Options Action
January 15, 2016 11:29 AM ESTTiffany & Co. (NYSE: TIF) ticks higher on options activity. Shares up 1.3%
... More